Frederico Omar Gleber-Netto

21PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPeripheral nervous systemCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 03, 2026
Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.

|Feb 10, 2026
β-Adrenergic Signaling Promotes Anti-Tumor Immunity in TP53-mutant Oral Squamous Cell Carcinoma.

Frederico O Gleber-Netto, Deborah Silverman, Tongxin Xie

|Jan 27, 2026
EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.

Naijiang Liu, Xiaojie Shi, Shao-Rui Chen

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

|Jun 10, 2025
Perineural Invasion Exhibits Traits of Neurodegeneration.

M Zhang, M Yuan, K Asam

|Sep 06, 2024
Targeting the peripheral neural-tumour microenvironment for cancer therapy.

Dan Yaniv, Brandi Mattson, Sebastien Talbot

Pageof 4

Frequent Collaborators

7 joint publications

Moran Amit

5 joint publications

Neil D Gross

5 joint publications

Jing Wang

5 joint publications

Jeffrey N Myers